Single-nucleotide polymorphisms (SNPs) in FKBP5 are associated with an increased risk for several psychiatric disorders, and FKBP5 has been implicated in Alzheimer’s disease (AD) by interfering with tau processing23,24. This evidence concerns the gene MAPT and Alzheimer disease.